» Articles » PMID: 38402384

Phenotypes of Osteoarthritis-related Knee Pain and Their Transition over Time: Data from the Osteoarthritis Initiative

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2024 Feb 24
PMID 38402384
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identification of knee osteoarthritis (OA) pain phenotypes, their transition patterns, and risk factors for worse phenotypes, may guide prognosis and targeted treatment; however, few studies have described them. We aimed to investigate different pain phenotypes, their transition patterns, and potential risk factors for worse pain phenotypes.

Methods: Utilizing data from the Osteoarthritis Initiative (OAI), pain severity was assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale. We identified the activity-related pain phenotypes and estimated the transition probabilities of pain phenotypes from baseline to the 24-month using latent transition analysis. We examined the risk factors at baseline with the 24-month pain phenotypes and the transition of pain phenotypes.

Results: In 4796 participants, we identified four distinct knee pain phenotypes at both baseline and 24-month follow-up: no pain, mild pain during activity (Mild P-A), mild pain during both rest and activity (Mild P-R-A), and moderate pain during both rest and activity (Mod P-R-A). 82.9% knees with no pain at baseline stayed the same at 24-month follow-up, 17.1% progressed to worse pain phenotypes. Among "Mild P-A" at baseline, 32.0% converted to no-pain, 12.8% progressed to "Mild P-R-A", and 53.2% remained. Approximately 46.1% of "Mild P-R-A" and 54.5% of "Mod P-R-A" at baseline experienced remission by 24-month. Female, non-whites, participants with higher depression score, higher body mass index (BMI), higher Kellgren and Lawrence (KL) grade, and knee injury history were more likely to be in the worse pain phenotypes, while participants aged 65 years or older and with higher education were less likely to be in worse pain phenotypes at 24-month follow-up visit. Risk factors for greater transition probability to worse pain phenotypes at 24-month included being female, non-whites, participants with higher depression score, higher BMI, and higher KL grade.

Conclusions: We identified four distinct knee pain phenotypes. While the pain phenotypes remained stable in the majority of knees over 24 months period, substantial proportion of knees switched to different pain phenotypes. Several socio-demographics as well as radiographic lesions at baseline are associated with worse pain phenotypes at 24-month follow-up visit and transition of pain phenotypes.

Citing Articles

Antidepressants to Manage Osteoarthritic Pain: The Value of Pain Phenotyping.

Zhang D, Deveza L, Tan B, Dear B, Hunter D Drugs Aging. 2025; 42(3):183-193.

PMID: 39976814 PMC: 11880052. DOI: 10.1007/s40266-025-01182-9.

References
1.
Riddle D, Kong X, Fitzgerald G . Psychological health impact on 2-year changes in pain and function in persons with knee pain: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2011; 19(9):1095-101. PMC: 3159740. DOI: 10.1016/j.joca.2011.06.003. View

2.
Stannus O, Jones G, Blizzard L, Cicuttini F, Ding C . Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis. 2012; 72(4):535-40. DOI: 10.1136/annrheumdis-2011-201047. View

3.
Haynes M, Hume E, Smith J . Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol. 2002; 105(3):315-25. DOI: 10.1006/clim.2002.5283. View

4.
Perrot S, Poiraudeau S, Kabir-Ahmadi M, Rannou F . Correlates of pain intensity in men and women with hip and knee osteoarthritis. Results of a national survey: The French ARTHRIX study. Clin J Pain. 2009; 25(9):767-72. DOI: 10.1097/AJP.0b013e3181b43d4f. View

5.
He D, Grant B, Holden R, Gilron I . Methodology for self-report of rest pain (or spontaneous pain) vs evoked pain in chronic neuropathic conditions: a prospective observational pilot study. Pain Rep. 2018; 2(2):e587. PMC: 5770175. DOI: 10.1097/PR9.0000000000000587. View